Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability
over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and …

Pulmonary arterial hypertension (PAH) is characterized by a progressive accumulation of
pulmonary artery smooth muscle cells (PA-SMCs) in pulmonary arterioles leading to the …

Background— Chronic thromboembolic pulmonary hypertension leads to pulmonary
hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy …

Speed estimation methods for sensorless induction motor drives can be divided into two
groups. One is based on information about fundamental components of stator currents and …

Study Design. Various amounts of static mechanical load were applied to mouse intervertebral
discs in organ cultures. The apoptosis then was examined using nick end labeling. Two …

Background Left ventricular ( LV ) remodeling leads to chronic heart failure and is a main
determinant of morbidity and mortality after myocardial infarction ( MI ). At the present time, …

Background: The trend of the initial treatment strategy for pulmonary arterial hypertension (PAH)
has changed from monotherapies to upfront combination therapies. This study analyzed …

Pulmonary arterial hypertension leads to significant impairment in haemodynamics, right
heart function, exercise capacity, quality of life and survival. Current therapies have …

Genetic causes of pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive
disease (PVOD) have been identified, leading to a growing need for genetic counselling. …

A retrospective multicenter registry including 49 institutions and 11 countries was built using
a Research Electronic Data Capture web-based platform with Institutional Review Board …